Jubilant Ingrevia Limited (BOM:543271)

Market Cap	111.76B
Revenue (ttm)	41.91B
Net Income (ttm)	2.78B
Shares Out	n/a
EPS (ttm)	17.51
PE Ratio	40.27
Forward PE	33.21
Dividend	5.00 (0.71%)
Ex-Dividend Date	Jul 25, 2025

Volume	12,522
Average Volume	10,491
Open	710.05
Previous Close	708.50
Day's Range	701.05 - 712.10
52-Week Range	556.55 - 884.95
Beta	n/a
RSI	37.46
Earnings Date	Jul 15, 2025

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition...

• Industry: Chemicals and Allied Products
• Founded: 2019
• Employees: 2,139
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543271

Financial Performance

In 2024, Jubilant Ingrevia's revenue was 41.78 billion, an increase of 1.01% compared to the previous year's 41.36 billion. Earnings were 2.51 billion, an increase of 37.34%.